Blood serum cytokines as predictors of hemorrhagic transformation of ischemic stroke

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 2014, Issue 3, 2014, Pages 20-26

  Nikiforova Postnikova, T A ^a   Doronin, B M ^a   Peskov, S A ^a,b  

^a NOVOSIBIRSK STATE MEDICAL UNIVERSITY   (Russian Federation)

^b Novosibirsk Regional Narcological Center   (Russian Federation)

Author keywords

Cytokines; Hemorrhagic transformation; Stroke

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLEEDING; BRAIN ISCHEMIA; HUMAN;

EID: 84905045936     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Khatri P., Lawrencye R., Broderick P. Intracranial hemorrhage associated with revascularization therapies. Stroke 2007; 38: 431-440.
2. Muir K., Muir P., Sattar N. Inflammation and ischaemic stroke. Curr Opin Neurol 2007; 20: 3: 334-342.
3. Wang Q., Tang Kh., Yenari M. The inflammatory response in stroke. J Neuroimmunol 2007; 184: 1-2: 53-68.
4. Tuttolomondo A., di Raimondo D., di Sciacca R. et al. Cytokines in acute ischemic stroke. Curr Pharm Des 2008; 14: 33: 3574-3589.
5. Oto J., Suzue A., Inui D. et al. Plasma proinflammatory and anti-inflammatory cytokine and catecholamine concentrations as predictors of neurological outcome in acute stroke patients. J Anesth 2008; 22: 3: 207-212.
6. Vila N., Castillo J., Vila N. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000; 31: 10: 2325-2329.
7. Fure B., Wyller T., Thommessen B. TOAST criteria applied in acute ischemic stroke. Acta Neurol Scand 2005; 112: 4: 254-258.
8. Liesz A., Middelhoff M., Zhou W. et al. Comparison of humoral neuroinflammation and adhesion molecule expression in two models of experimental intracerebral hemorrhage. Stroke 2011; 3: 1: 11.
9. Prass K., Meisel S., Hoflich S. et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and sympathetic activation reversal by poststroke T helper immunostimulation. J Exp Med 2003; 198: 5:725-736.
10. Galea J., Brough D. The role of inflammation and interleukin-1 in acute cerebrovascular disease. J Inflamm Res 2013; 6: 121-128.
11. Offner H., Vandenbark A., Hurn R. Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience 2009; 158: 3: 1098-1111.
12. Liesz A., Hagmann S., Zschoche S. et al. The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation. Stroke 2009; 40: 8: 2849-2858.
13. Hebbrecht G., Maenhaut W., De Reuck J. Comparison of trace element alterations and water content in haemorrhagic and non-haemorrhagic cerebral infarcts. Cerebrovasc Dis 1994; 4: 412-416.
14. Wang C., Shuaib A. Critical role of microvasculature basal lamina in ischemic brain injury. Prog Neurobiol 2007; 83: 3: 140-148.
15. Yamada Y., Metoki N., Yoshida N. et al. Genetic risk for ischemic and hemorrhagic stroke. Arterioscler Thromb Vasc Biol 2006; 26: 8: 1920-1925.
16. Romanic A., White R., Arleth A. et al. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase- 9 reduces infarct size. Stroke 1998; 29: 5: 1020-1030.
17. Beamer N., Coull M., Clark M. et al. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol 1995; 37: 6: 800-805.
18. Basic Kes V., Simundic A., Nikolac N. et al. Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome. Clin Biochem 2008; 41: 1330-1334.
19. Dziedzic T. Clinical significance of acute phase reaction in stroke patients. Front Biosci 2008; 13: 2922-2927.
20. Orion D., Schwammenthal Y., Reshef T. et al. Interleukin-6 and soluble intercellular adhesion molecule-1 in acute brain ischemia. Eur J Neurol 2008; 15: 4: 323-328.
21. Shakarishvili R., Beridze M. Proinflammatory reactants as determinants of stroke severity in elderly. Georgian Med News 2008; 162: 23-27.
22. Pelidou S., Kostulas D., Matusevicius N. et al. High levels of IL-10 secreting cells in blood in cerebrovascular diseases. Eur J Neurol 1999; 6: 4: 437-442.
23. Vila N., Castillo J., Davalos A. et al. Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke 2003; 34: 3: 671-675.
24. Xiong X., Barreto G., Xu L. et al. Increased Brain Injury and Worsened Neurological Outcome in Interleukin-4 Knockout Mice After Transient Focal Cerebral Ischemia. Stroke 2011; 42: 7: 2026-2032.
25. Arumugam T.V., Granger D.N., Mattson M. Stroke and T-cells. Neuromolecular Med 2005; 7: 3: 229-242.